The Immune System and Cellular Senescence: A Complex Interplay in Aging and Disease.
Immunosenescence is the process of immune dysfunction and gradual deterioration of the immune system associated with aging, while cellular senescence is the stable cell cycle arrest that can occur in
APA
Ayoub M, Abou Jaoude C, et al. (2026). The Immune System and Cellular Senescence: A Complex Interplay in Aging and Disease.. Immunology, 177(1), 149-169. https://doi.org/10.1111/imm.70036
MLA
Ayoub M, et al.. "The Immune System and Cellular Senescence: A Complex Interplay in Aging and Disease.." Immunology, vol. 177, no. 1, 2026, pp. 149-169.
PMID
40937638
Abstract
Immunosenescence is the process of immune dysfunction and gradual deterioration of the immune system associated with aging, while cellular senescence is the stable cell cycle arrest that can occur in non-immune or immune cells in response to stress or damage. Immunosenescence significantly impacts both the innate and adaptive immune responses and is characterised by physical changes in lymphoid organs, as well as dysfunctions in cellular and molecular mechanisms. Key features of immunosenescence include T-cell dysfunction, thymic involution, B cell aging, an imbalance in the ratio of naïve to memory cells, chronic inflammation known as inflammaging and metabolic dysregulation. This decline in immune cell diversity and functionality contributes to various age-related diseases. Therefore, restoring a more 'juvenile' immune function in aging populations, through interventions targeting immunosenescence, holds promise for alleviating many age-related diseases and promoting healthier aging. In this review, we provide a comprehensive understanding of the interplay between the immune system and senescent cells in both healthy and disease contexts. We then dissect the immune dysfunction that occurs with aging, known as immunosenescence, and explore its impact on the health of elderly individuals. Finally, we discuss recent advances in targeting immune system aging to promote healthier longevity, with a special focus on Programmed Death-Ligand 1 (PD-L1), an emerging and promising target for therapeutic intervention.
MeSH Terms
Humans; Cellular Senescence; Immunosenescence; Aging; Immune System; Animals; B7-H1 Antigen
같은 제1저자의 인용 많은 논문 (2)
- Olaparib sensitizes chronic lymphocytic leukemia to BTK- and BCL2-targeted therapies via PARP1-independent mitochondrial metabolic dysfunction.
- Risk of Esophageal and Gastric Cancer in Patients with Type 2 Diabetes Receiving Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A National Analysis.